# A Phase 1 Clinical Study of CU-20401 in Chinese Healthy Population

> **NCT05173883** · PHASE1 · COMPLETED · sponsor: **Cutia Therapeutics（Wuxi）Co.,Ltd** · enrollment: 48 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** injection ，CU-20401
- **DRUG:** injection ，placebo

## Key facts

- **NCT ID:** NCT05173883
- **Lead sponsor:** Cutia Therapeutics（Wuxi）Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-20
- **Primary completion:** 2023-11-02
- **Final completion:** 2023-11-02
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2024-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05173883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05173883, "A Phase 1 Clinical Study of CU-20401 in Chinese Healthy Population". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05173883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*